| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc483459e58e5df945c123ddc3ea8d3e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-645 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-162 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16 |
| filingDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8fdd8e6e5bb425dd41455a3793f899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f11f20f1270326058f31dc3880da7f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a160dfda1ba7aed6a1755e3a8a0d0ad |
| publicationDate |
2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111423987-A |
| titleOfInvention |
A kind of marine fungi-derived azaphilones dimer compound and its application in anti-tuberculosis drugs |
| abstract |
The invention provides a marine fungus-derived azaphilones dimer compound and its application in an anti-tuberculosis drug. The structural formula of the compound is shown in formula 1 or formula 2. The HBU-135 strain of Pleosporales sp. is cultured by fermentation, and the above-mentioned compounds are isolated from the fermentation product. It has been verified that the compound of the present invention has strong inhibitory activity against multidrug-resistant Mycobacterium tuberculosis (MDR-TB), can be used as an anti-tuberculosis drug, and has broad application prospects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113527247-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113527247-A |
| priorityDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |